Newsletter Subject

Daily Headlines: FDA Panel Backs New Warning for Gadolinium Contrast Agents

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Sep 12, 2017 12:05 PM

Email Preheader Text

Daily Headlines September 12, 2017 CME/CE CME/CE Additional Resources Industry Resources [Official S

Daily Headlines September 12, 2017 [FDA Panel Backs New Warning for Gadolinium Contrast Agents]( [ERS: Disinfectant Use Tied to COPD Incidence in Nurses]( CME/CE [Wife's BMI Weighs on Husband's Diabetes Risk]( [Early Anticoagulation Strategies Comparable After Afib-Related Stroke]( CME/CE [Bill to Fight Opioid Epidemic: HealthLeaders Media]( Additional Resources [Diagnosis and Treatment of Relapsed Myeloma]( [AML: Beware of Pre-leukemic Clones Surviving Chemotherapy]( [Support for Omitting ALND in Early Breast Cancer]( Industry Resources [Multiple Myeloma Potential Immuno-Oncology 2nd Line Treatment for Multiple Myeloma]( [CGRP Pathway and Migraine MDs, Watch a Video on Migraine and The Science Behind It]( [Official Site for HCPs Learn About Repatha® (evolocumab) by Visiting the Official Website]( Recent Headlines [10 Questions to Challenge Your Medical News Savvy]( [Urban Kids with Asthma May Benefit from Green Space]( [PI3K Inhibitor Ups Response in Early Breast Cancer]( [PodMed: A Medical News Roundup From Johns Hopkins]( [D.C. Week: Governors, Insurers Advise Senate on ACA Exchanges]( ADVERTISEMENT This Week's Survey [Are Statin Harms Exaggerated?]( [The Cleveland Clinic's Steve Nissen, MD, says the internet is rampant with misinformation that]([statins do more harm than good](, and that doctors need to fight back with the facts CME Spotlights [MDS and Acute Myeloid Leukemia (MDS and AML) @Point of Care]( [Source: @Point of Care]( [Skin Cancers @Point of Care]( [Source: @Point of Care]( [Outcomes in NSCLC: A Focus on Quality Improvement-Part1]( [Source: RMEI Medical Education]( [Treatment of a Relapsing High-Risk Multiple Myeloma Patient]( [Source: Projects In Knowledge, Inc.]( [Hematology CLL @POC]( [Source: @Point of Care]( [Multiple Myeloma (MM) @Point of Care|Grant|App]( [Source: @Point of Care]( [Treatment of Platinum-Resistant Recurrent Ovarian Epithelial Cancer]( [Source: Projects in Knowledge, Inc.]( [Treatment of Recurrent Cervical Squamous Cell Carcinoma]( [Source: Projects In Knowledge, Inc.]( [Role of Immunomodulatory Drug Therapy in a Patient with Refractory Multiple Myeloma]( [Source: Projects In Knowledge, Inc.]( [Newly Diagnosed Metastatic Prostate Cancer Patient]( [Source: Projects In Knowledge, Inc.]( [Relapsing-Remitting Multiple Sclerosis Patient Who Relapses on Current Treatment]( [Source: Projects In Knowledge, Inc.]( [A Multidisciplinary Approach to Management in Basal Cell Carcinoma]( [Source:Postgraduate Institute for Medicine and DKBMed]( [Basal Cell Carcinoma: A Comprehensive Team Approach to Management]( [Source:Postgraduate Institute for Medicine and DKBMed]( [Breast Cancer @POC]( [Source: @Point of Care]( [Evidence-Based Patient-Centered Management in NSCLC]( [Source: Postgraduate Institute for Medicine and DKBMed]( [Approaches to Managing the Complex Patient with NSCLC]( [Source: Postgraduate Institute for Medicine and DKBMed]( [Biosimilar vs. Generic... Are they the same? What do you say to your patient?]( [Source: France Foundation]( [Managing Treatment-Related Diarrhea in a Patient With MDS]( [In this case study, Donald P. Kotler, MD, examines the possible causes and solutions for lenalidomide-related diarrhea in a patient with MDS. Source:Clinical Care Options]( [Relapsing/Refractory Multiple Myeloma in a High Risk Patient]( [Source: Projects in Knowledge]( More of Today's Stories [CBC Count Fails for Predicting Infant Bacterial Infections]( CME/CE [Bone Loss Drug Effective, But is it Safe?]( CME/CE [iMedicalApps: Is Virtual Reality a Good Adjunct to Anesthesia?]( [Birmingham Score Predicts CV Events, Death in Vasculitis]( CME/CE [Another Study Ties Sitting to Mortality Risk]( CME/CE [CardioBrief: Is Cardiology Flatlining?]( [The State of Dermatology]( [What Does ROI Say About Drug Pricing?]( [Anti-PD 1 Drug Extends PFS in Stage III NSCLC]( CME/CE [Do Interim Results Need A Warning Label?]( [Mastery of Medicine in Diabetes Management: A Video Roundtable]( CME/CE [Gasping for Air, A Predictor of Survival After OHCA]( [The Continuing Myth of the 'Metabolically Healthy'?]( CME/CE [Absorb Stent Off Market; 9/11 Dust Lipid Effects; New AUC in Valvular Imaging]( [Sequential Therapy a Winner in Osteoporosis]( CME/CE [Do Asthmatic Kids Get More Antibiotics?]( CME/CE [Another Win for PARP Inhibition in Ovarian Cancer]( CME/CE [Vaccines and Adverse Events: Are You Tracking Reports?]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [EverydayHealth] © Copyright 2017 Everyday Health, Inc. All rights reserved. Use of this site constitutes acceptance of the MedPageToday.com [terms of use]( and [privacy policy.]( The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address:{EMAIL} [Manage my e-mail settings]( | [Unsubscribe from "Daily Headlines"](lst=Daily%20Headlines) Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.